The R122C mutation was shown to completely abrogate the function of RUNX3 as a tumor suppressor; while overexpression of RUNX3 slowed the proliferation of different cancer cells, overexpression of the R122C mutant failed to inhibit cell proliferation. This evidence concerns the gene RUNX3 and neoplasm.